Possible novel pharmacodynamic action of cocaine: Cardiovascular and behavioral evidence

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 2, 1996, Pages 343-354

  Tella, Srihari Rao ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Cardiovascular effects; Cocaine; Monoamine reuptake; Novel pharmacodynamic action; Sodium channel

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADRENALIN; CHLORISONDAMINE; COCAINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ECOPIPAM; ETICLOPRIDE; FENOLDOPAM MESILATE; FLUOXETINE; ISOPRENALINE; LIDOCAINE; NISOXETINE; NORADRENALIN; NORADRENALIN BITARTRATE; QUINPIROLE; SEROTONIN UPTAKE INHIBITOR; VANOXERINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AROUSAL; ARTICLE; BEHAVIOR; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NEUROPHARMACOLOGY; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030006896     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02145-0     Document Type: Article

References (93)

1. Anderson, P. H. The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:493-504; 1989.
2. Beltrame, J.; Aylward, P. E.; McRitchie, R. J.; Chalmers, J. P. Comparative hemodynamic effects of lidocaine, mexiletine, and disopyramide. J. Cardiovasc. Pharmacol. 6:483-490; 1984.
3. Bergman, J.; Madras, B. K.; Johnson, S. E.; Spealman, R. D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251:150-155; 1989.
4. Berthold, C. W., III; Gonzales, R. A.; Moerschbaecher, J. M. Prazosin attenuates the effects of cocaine on motor activity but not on schedule-controlled behavior in the rat. Pharmacol. Biochem. Behav. 43:111-115; 1992.
5. Blair, M. R. Cardiovascular pharmacology of local anesthetics. Br. J. Anesth. 47:247-252; 1975.
6. 2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39:911-915; 1991.
7. Brockway, B. P.; Mills, P. A.; Azar, S. H. A new method for continuous chronic measurement and recording of blood pressure, heart rate, and activity in the rat via radio-telemetry. Clin. Exp. Hypertens. Theory Practice A13:885-895; 1991.
8. Carroll, M. E.; Krattiger, K. L.; Gieske, D.; Sadoff, D. A. Cocaine-base smoking in rhesus monkeys: Reinforcing and physiological effects. Psychopharmacology (Berlin) 102:443-450; 1990.
9. Cavero, I.; Lefevre-Borg, F.; Gomeni, R. Heart rate lowering effects of N,N-di-n-propyl-dopamine in rats: Evidence for stimulation of central dopamine receptors leading to inhibition of sympathetic tone and enhancement of parasympathetic outflow. J. Pharmacol. Exp. Ther. 219:510-519; 1981.
10. Chen, B. X.; Wilkerson, R. D. Role of sympathetic neurons and adrenal medulla in the cardiovascular response to cocaine in conscious, unrestrained rats. (Abstract). FASEB J. 6:A1177; 1992.
11. Chiueh, C. C.; Kopin, I. J. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther. 205:148-154; 1978.
12. 125I]RTI-55 to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse 12:37-46; 1992.
13. 2 dopamine antagonists. Pharmacol. Biochem. Behav. 39:799-802; 1991.
14. Cousineau, D.; Goresky, C. A.; Rose, C. P. Decreased basal cardiac interstitial norepinephrine release after neuronal uptake inhibition in dogs. Circ. Res. 58:859-866; 1986.
15. Cunningham, K. A.; Callahan, P. M. Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology (Berlin) 104:177-180; 1991.
16. Dackis, C. A.; Gold, M. S.; Davies, R. K.; Sweeney, D. R. Bromocriptine treatment for cocaine abuse: The dopamine depletion hypothesis. Int. J. Psychiatr. Med. 15:125-135; 1985.
17. 2 receptor agonist on the sympathoadrenal system in dogs. J. Pharmacol. Exp. Ther. 252:770-777; 1990.
18. Dorward, P. K.; Saigusa, T.; Eisenhofer, G. Differential effects of central and peripheral desipramine on sympathoadrenal function and HR in conscious rabbits. J. Cardiovasc. Pharmacol. 17: 519-531; 1991.
19. Edouard, A.; Berdeaux, A.; Langloys, J.; Samii, K.; Giudicelli, J. F.; Noviant, Y. Effects of lidocaine on myocardial contractility and baroreflex control of heart rate in conscious dogs. Anesthesiology 64:316-321; 1986.
20. Fischman, M. W.; Schuster, C. R. Cocaine self-administration in humans. Fed. Proc. 41:241-246; 1982.
21. Fischman, M. W.; Schuster, C. R.; Hatano, Y. A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans. Pharmacol. Biochem. Behav. 18:123-127; 1983.
22. Fischman, M. W.; Schuster, C. R.; Resnekov, L.; Shick, J. F. E.; Krasnegor, N. A.; Fennell, W.; Freedman, D. X. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiatry 33:983-989; 1976.
23. Garfield, J. M.; Gugino, L. Central effects of local anesthetic agents. In: Strichartz, G. R., ed. Local anesthetics. New York: Springer Verlag; 1987:253-284.
24. Gawin, F. H.; Kleber, H. D.; Byck, R.; Rounsaville, M. D.; Kosen, R. R.; Jatlow, P. I.; Morgan, C. Desipramine facilitation of initial cocaine abstinence. Arch. Gen. Psychiatry 46:117-121; 1989.
25. Gonzalez, F. A.; Byrd, L. D. Physiological effects of cocaine in the squirrel monkey. Life Sci. 21:1417-1424; 1977.
26. Hofman, W. F.; Jerram, D. C.; Gangarosa, L. P. Cardiorespiratory and behavioral reactions to the lidocaine-induced convulsion in the dog. Res. Commun. Chem. Pathol. Pharmacol. 16:581-591; 1977.
27. Howell, L. L.; Byrd, L. D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J. Pharmacol. Exp. Ther. 258:178-185; 1991.
28. 2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berlin) 105:151-156; 1991.
29. Javaid, J. I.; Fischman, M. W.; Schuster, C. R.; Dekirmenjian, H.; David, J. M. Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Science 202:227-228; 1978.
30. Johanson, C. E.; Fischman, M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:3-52; 1989.
31. Jorfeldt, L.; Lofstrom, B.; Pernow, B.; Wahren, J. The effect of mepivacaine and lidocaine on forearm resistance and capacitance vessels in man. Acta Anesth. Scand. 14:183-201; 1970.
32. Kao, F. F.; Jalar, U. H. The central action of lignocaine and its effect on cardiac output. Br. J. Pharmacol. 14:522-526; 1959.
33. Kelly, P. H.; Iversen, S. D. Selective 6-OHDA induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40: 45-56; 1976.
34. Kennedy, L. T.; Hanbauer, I. Sodium-sensitive cocaine binding to striatal membranes: Possible relationship to dopamine uptake sites. J. Neurochem. 41:172-178; 1983.
35. Kiritsy-Roy, J. A.; Halter, J. B.; Gordon, S. M.; Smith, M. J.; Terry, L. C. Role of the nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmacol. Exp. Ther. 255:154-160; 1990.
36. Kleven, M. S.; Woolverton, W. L. Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys. Psychopharmacology (Berlin) 101:208-213; 1990.
37. Knuepfer, M. M.; Branch, C. A. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J. Pharmacol. Exp. Ther. 263:734-741; 1992.
38. Koob, G. F.; Stinus, L.; Le Moal, M. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav. Brain Res. 3:341-359; 1981.
39. Kosten, T. R.; Morgan, C. M.; Falcione, J.; Schottenfeld, R. S. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch. Gen. Psychiatry 49:894-898; 1992.
40. Krulan, C.; Bazil, M. K.; Webb, R. L. Comparison of cardiovascular parameters measured with telemetry and directly via in-dwelling catheters (INC) in conscious spontaneously hypertensive rats (SHR). FASEB J. 6:A1174; 1992.
41. Lacosta, S.; Roberts, D. C. S. MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine. Pharmacol. Biochem. Behav. 44:161-165; 1993.
42. Lange, J.; Brockway, B.; Azan, S. Telemetric monitoring of laboratory animals: An advanced technique that has come of age. Lab. Anim. 20:28-34; 1991.
43. Lescanic, M. L.; Miller, E. D.; DiFazio, C. A. The effects of lidocaine on the whole body distribution of radioactively labeled microspheres in the conscious rat. Anesthesiology 55:269-272; 1981.
44. 3H]Cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251:131-141; 1989.
45. Mandel, W. J.; Laks, M. M.; Arieff, A. I.; Obayashi, K.; Hayakawa, H.; McCullen, A. Cardiorenal effects of lidocaine and procaine in the conscious dog. Am. J. Physiology. 228:1440-1445; 1975.
46. Matsuzaki, M.; Spingler, P. J.; Whitlock, E. G.; Misra, A. L.; Mule, S. J. Comparative effects of cocaine and pseudococaine on EEG activities, cardiorespiratory functions, and self-administration behavior in the rhesus monkey. Psychopharmacology (Berlin) 57:13-20; 1978.
47. Meert, T. F.; Janssen, P. A. J. Ritanserin, a new therapeutic approach for drug abuse. Part 2: Effects on cocaine. Drug Dev. Res. 25:39-53; 1992.
48. Pollack, M. H.; Rosenbaum, J. F. Fluoxetine treatment of cocaine abuse in heroin addicts. J. Clin. Psychiatry 52:31-33; 1991.
49. Post, R. M.; Weiss, S. R. B.; Pert, A.; Uhde, T. W. Chronic cocaine administration: Sensitization and kindling effects. In: Rusher, S.; Raskin, A.; Uhlenhuth, E. H., eds. Cocaine: Clinical and behavioral aspects. New York: Oxford University Press; 1987:109-173.
50. 3 antagonists attenuate cocaine-induced locomotion in mice. Eur. J. Pharmacol. 186:327-330; 1990.
51. Reith, M. E. A.; Meisler, B. E.; Sershen, H.; Lajtha, A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35:1123-1129; 1986.
52. Reith, M. E. A.; Weiner, H. L.; Fischette, C. T. Sertraline and cocaine-induced locomotion in mice. I. Acute studies. Psychopharmacology (Berlin) 103:297-305; 1991.
53. Resnick, R. B.; Kestenbaum, R. S.; Schwartz, L. K. Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes. Science 195:696-698; 1977.
54. Ritz, M. C.; Lamb, R. J.; Goldberg, S. R.; Kuhar, M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223; 1987.
55. Rothman, R. B.; Greig, N.; Kim, A.; De Costa, B. R.; Rice, K. C.; Carroll, F. I.; Pert, A. Cocaine and GBR 12909 produce equivalent locomotor responses at different occupancy of the dopamine transporter. Pharmacol. Biochem. Behav. 43:1135-1142; 1992.
56. Rutten, A. J.; Nancarrow, C.; Mather, L. E.; Ilsley, A. H.; Runciman, W. B.; Upton, R. N. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth. Analg. 69:291-299; 1989.
57. 123/125I]RTI-55, an in vivo label for the serotonin transporter. Synapse 11:134-139; 1992.
58. 3H]WIN 35,428. J. Pharmacol. Exp. Ther. 257:954-958; 1991.
59. Schindler, C. W.; Tella, S. R.; Katz, J. L.; Goldberg, S. R. Effects of cocaine and its quaternary derivative cocaine methiodide on cardiovascular function in squirrel monkeys. Eur. J. Pharmacol. 213:99-105; 1992.
60. Schindler, C. W.; Tella, S. R.; Witkin, J. M.; Goldberg, S. R. Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys. Life Sci. 48:1547-1554; 1991.
61. Schnell, C. R.; Wood, J. M. Measurement of blood pressure and heart rate by telemetry in conscious, unrestrained marmosets. Am. J. Physiol. 264:H1509-H1516; 1993.
62. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in parkinson disease. Naunyn Schmiedebergs Arch. Pharmacol. 329:227-235; 1985.
63. Silverman, P. B.; Schultz, K. A. Comparison of cocaine and procaine discriminative stimuli. Drug Dev. Res. 16:427-433; 1989.
64. Spealman, R. D. Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers. Psychopharmacology (Berlin) 101:142-145; 1990.
65. Spealman, R. D.; Bergman, J.; Madras, B. K.; Melia, K. F. Discriminative stimulus effects of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258:945-953; 1991.
66. Spealman, R. D.; Madras, B. K.; Bergman, J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 251:142-149; 1989.
67. Strichartz, G. R.; Ritchie, J. M. The action of local anesthetics on ion channels of excitable tissues. In: Strichartz, G. R., ed. Local anesthetics. New York: Springer Verlag; 1987:21-52.
68. Szabo, B.; Schultheiss, A. Desipramine inhibits sympathetic nerve activity in the rabbit. Naunyn Schmiedebergs Arch. Pharmacol. 342:469-476; 1990.
69. 3 antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism. Pharmacol. Biochem. Behav. 43: 871-879; 1992.
70. 3H]nisoxetine: A radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260:427-436; 1992.
71. Tella, S. R. Differential blockade of chronic vs. acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48:151-159; 1994.
72. Tella, S. R.; Korupolu, G. R.; Schindler, C. W.; Goldberg, S. R. Pathophysiological and pharmacological mechanisms of acute cocaine toxicity in conscious rats. J. Pharmacol. Exp. Ther. 262: 936-946; 1992.
73. Tella, S. R.; Schindler, C. W.; Goldberg, S. R. The role of central and autonomie neural mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys. J. Pharmacol. Exp. Ther. 252:491-499; 1990.
74. Tella, S. R.; Schindler, C. W.; Goldberg, S. R. Cardiovascular effects of cocaine in conscious rats: Relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms. J. Pharmacol. Exp. Ther. 262: 602-610; 1992.
75. Tella, S. R.; Schindler, C. W.; Goldberg, S. R. Cocaine: Cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J. Pharmacol. Exp. Ther. 267:153-162; 1993.
76. Tella, S. R.; Schindler, C. W.; Goldberg, S. R. Chlorisondamine, a noncompetitive ganglionic blocker, antagonizes the cardiovascular effects of cocaine in conscious squirrel monkeys. Pharmacol. Res. 27:233-239; 1993.
77. Tennant, F. S.; Sagherian, A. A. Double-blind comparison of amantadine hydrochloride and bromocriptine mesylate for ambulatory withdrawal from cocaine dependence. Arch. Int. Med. 147: 109-112; 1987.
78. Tessel, R. E. Noradrenergic processes in the behavioral actions of psychomotor stimulants. Drug Dev. Res. 20:359-368; 1990.
79. Van Der Zee, P.; Koger, H. S.; Gootjes, J.; Hespe, W. Aryl 1,4-dialk(en)ylpiperazines as selective and very potent inhibitors of dopamine uptake. Eur. J. Med. Chem. 15:363-370; 1980.
80. Van Haaren, F. Effects of cocaine alone and in combination with prazosin or ondansetron on multiple fixed-interval fixed-ratio performance in pigeons. Pharmacol. Biochem. Behav. 42:849-853; 1992.
81. Weddington, W. W.; Brown, B. S.; Haertzen, C. A.; Hess, J. M.; Mahaffey, J. R.; Kolar, A. F.; Jaffe, J. H. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am. J. Drug Alcohol Abuse 17:137-152; 1991.
82. Weiss, S. R. B.; Post, R. M.; Pert, A.; Woodward, R.; Murman, D. Context-dependent cocaine sensitization: Differential effect of haloperidol on development vs. expression. Pharmacol. Biochem. Behav. 34:655-661; 1989.
83. Wilkerson, R. D. Cardiovascular effects of cocaine in conscious dogs: Importance of fully functional autonomic and central nervous systems. J. Pharmacol. Exp. Ther. 246:466-471; 1988.
84. Wilkinson, L. SYSTAT: The system for statistics. Evanston, IL: SYSTAT, Inc.; 1989.
85. Wiklund, L. Human hepatic blood flow and its relation to systemic circulation during intravenous infusion of lidocaine. Acta Anesthesiol. Scand. 21:148-160; 1977.
86. Winger, G. Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav. Pharmacol. 5:141-152; 1994.
87. Witkin, J. M.; Nicholos, D. E.; Terry, P.; Katz, J. L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:706-713; 1991.
88. Wong, D. T.; Bymaster, F. P.; Horng, J. S.; Molloy, B. B. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenyl-propylamine. J. Pharmacol. Exp. Ther. 193:804-811; 1975.
89. Wong, D. T.; Bymaster, F. P.; Reid, L. R.; Threlkeld, P. G. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem. Pharmacol. 32:1287-1293; 1983.
90. Wong, D. T.; Threlkeld, P. G.; Best, K. L.; Bymaster, F. P. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J. Pharmacol. Exp. Ther. 222:61-65; 1982.
91. Woolverton, W. L.; Kleven, M. S. Multiple dopamine receptors and the behavioral effects of cocaine. Natl. Inst. Drug Abuse Res. Monogr. 88:160-184; 1988.
92. Yokoyama, M.; Benson, K. T.; Arakawa, K.; Goto, H. Effects of flumazenil on intravenous lidocaine-induced convulsions and anticonvulsant property of diazepam in rats. Anesth. Analg. 75: 87-90; 1992.
93. Yoshida, K. I.; Morimoto, A.; Makisumi, T.; Murakami, N. Cardiovascular, thermal and behavioral sensitization to methamphetamine in freely moving rats. J. Pharmacol. Exp. Ther. 267: 1538-1543; 1993.